Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer J Arnold

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
BMJ Clinical Evidence|February 25, 2016
Age-related macular degeneration: anti-vascular endothelial growth factor treatmentJennifer J Arnold
BMJ Clinical Evidence|May 21, 2009
Age related macular degenerationJennifer J Arnold, Wilson Heriot
Retinal Cases & Brief Reports|November 13, 2014
Four-month back pain after verteporfin treatment: clinical case notesClare L Fraser, Jennifer J Arnold
BMC Ophthalmology|March 25, 2016
The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration--a phase IV randomised clinical trial with ranibizumab: the FLUID studyJennifer J Arnold, Caroline M Markey, Nicol P Kurstjens, et al.
Ophthalmology|October 7, 2016
Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data from an Observational StudyMark C Gillies, Vuong Nguyen, Vincent Daien, et al.
The British Journal of Ophthalmology|August 26, 2021
Dexamethasone intravitreal implant in treatment-naïve diabetic macular oedema: findings from the prospective, multicentre, AUSSIEDEX studySamantha Fraser-Bell, Hyong Kwon Kang, Paul Mitchell, et al.
Clinical & Experimental Ophthalmology|May 29, 2020
Four-week outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degenerationShaan Wiryasaputra, Vuong Nguyen, Jennifer J Arnold, et al.
The British Journal of Ophthalmology|October 21, 2017
Impact of baseline Diabetic Retinopathy Severity Scale scores on visual outcomes in the VIVID-DME and VISTA-DME studiesGiovanni Staurenghi, Nicolas Feltgen, Jennifer J Arnold, et al.
Eye (London, England)|November 26, 2020
Extended intervals for wet AMD patients with high retreatment needs: informing the risk during COVID-19, data from real-world evidenceKelvin Yi Chong Teo, Vuong Nguyen, Daniel Barthelmes, et al.
Investigative Ophthalmology & Visual Science|December 19, 2009
Pretreatment with intravitreal triamcinolone before laser for diabetic macular edema: 6-month results of a randomized, placebo-controlled trialMark C Gillies, Ian L McAllister, Meidong Zhu, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
BMJ Clinical Evidence|February 25, 2016
Age-related macular degeneration: anti-vascular endothelial growth factor treatmentJennifer J Arnold
BMJ Clinical Evidence|May 21, 2009
Age related macular degenerationJennifer J Arnold, Wilson Heriot
Retinal Cases & Brief Reports|November 13, 2014
Four-month back pain after verteporfin treatment: clinical case notesClare L Fraser, Jennifer J Arnold
BMC Ophthalmology|March 25, 2016
The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration--a phase IV randomised clinical trial with ranibizumab: the FLUID studyJennifer J Arnold, Caroline M Markey, Nicol P Kurstjens, et al.
Ophthalmology|October 7, 2016
Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data from an Observational StudyMark C Gillies, Vuong Nguyen, Vincent Daien, et al.
The British Journal of Ophthalmology|August 26, 2021
Dexamethasone intravitreal implant in treatment-naïve diabetic macular oedema: findings from the prospective, multicentre, AUSSIEDEX studySamantha Fraser-Bell, Hyong Kwon Kang, Paul Mitchell, et al.
Clinical & Experimental Ophthalmology|May 29, 2020
Four-week outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degenerationShaan Wiryasaputra, Vuong Nguyen, Jennifer J Arnold, et al.
The British Journal of Ophthalmology|October 21, 2017
Impact of baseline Diabetic Retinopathy Severity Scale scores on visual outcomes in the VIVID-DME and VISTA-DME studiesGiovanni Staurenghi, Nicolas Feltgen, Jennifer J Arnold, et al.
Eye (London, England)|November 26, 2020
Extended intervals for wet AMD patients with high retreatment needs: informing the risk during COVID-19, data from real-world evidenceKelvin Yi Chong Teo, Vuong Nguyen, Daniel Barthelmes, et al.
Investigative Ophthalmology & Visual Science|December 19, 2009
Pretreatment with intravitreal triamcinolone before laser for diabetic macular edema: 6-month results of a randomized, placebo-controlled trialMark C Gillies, Ian L McAllister, Meidong Zhu, et al.
Pageof 6